jdtic
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2011 (NCT01431586)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Kappa opioid receptorANTAGONIST
OPRK1 antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1- Mol. weight
- 465.64 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL415247 ↗
Also known as
- jdtic
- jdtic
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01431586 | Phase 1 | Aug 31, 2011 | Celerion, National Institute on Drug Abuse (NIDA), RTI International |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celerion | For profit | 1 | 0 | 1 | 2011 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2011 |
| RTI International | Academic/Hospital | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1